Redbud has introduced its microfluidics sample prep platform, called Redbud NA1, for use in research and surveillance for ...
Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug ...
18h
VELO on MSNThis Week in Tech: Vittoria Aero Tires, a Value Gravel Bike with Huge Tire Clearance, and Pas Normal Updates Its KitsThere are always new bike bits, bobs, products, and gear to share. This week in tech news comes all over the spectrum of ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
EMERYVILLE, CA, USA I March 10, 2025 I 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing ...
7h
News-Medical.Net on MSNAlready approved drug avapritinib Shows Promise in Treating High-Grade GliomasHigh-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...
A California company offering the world's first injectable CBD product is in hot water after the FDA said the IV injections ...
Lipocine (LPCN) announced that the FDA has recently informed sponsors of approved testosterone products about class-wide labeling changes. This ...
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a ...
Discover how outsourcing regulatory submission content development improves efficiency and ensures compliance.
Only nine of 25 states with an approved Medicaid SPA for an innovative payment arrangement addressing novel and expensive ...
The Senate Committee on Health, Labor and Pensions voted Thursday to approve Marty Makary as commissioner of the Food and Drug Administration. He will likely be confirmed in the full Senate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results